<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="vetsci-02-00456-t001" position="anchor">
 <object-id pub-id-type="pii">vetsci-02-00456-t001_Table A1</object-id>
 <label>Table A1</label>
 <caption>
  <p>Treatment options (antiviral drugs) for FIV-infected cats (including EBM grades for judgment of the available efficacy data; EBM grades used according to the European Advisory Board of Cat Diseases (ABCD).</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Drug</th>
    <th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Efficacy 
     <italic>In Vitro</italic>
    </th>
    <th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Efficacy 
     <italic>in Vivo</italic>
    </th>
    <th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Author’s Personal Opinion</th>
    <th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Ebm Level (I–Iv)</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td colspan="4" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1">
     <italic>
      <bold>Nucleoside Analogue—Reverse Transcriptase Inhibitors</bold>
     </italic>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"> </td>
   </tr>
   <tr>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Zidovudine (AZT)</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">yes [
     <xref rid="B27-vetsci-02-00456" ref-type="bibr">27</xref>,
     <xref rid="B14-vetsci-02-00456" ref-type="bibr">14</xref>,
     <xref rid="B16-vetsci-02-00456" ref-type="bibr">16</xref>,
     <xref rid="B17-vetsci-02-00456" ref-type="bibr">17</xref>,
     <xref rid="B18-vetsci-02-00456" ref-type="bibr">18</xref>,
     <xref rid="B19-vetsci-02-00456" ref-type="bibr">19</xref>,
     <xref rid="B20-vetsci-02-00456" ref-type="bibr">20</xref>,
     <xref rid="B22-vetsci-02-00456" ref-type="bibr">22</xref>,
     <xref rid="B23-vetsci-02-00456" ref-type="bibr">23</xref>,
     <xref rid="B24-vetsci-02-00456" ref-type="bibr">24</xref>,
     <xref rid="B25-vetsci-02-00456" ref-type="bibr">25</xref>,
     <xref rid="B26-vetsci-02-00456" ref-type="bibr">26</xref>,
     <xref rid="B38-vetsci-02-00456" ref-type="bibr">38</xref>]
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">yes [
     <xref rid="B76-vetsci-02-00456" ref-type="bibr">76</xref>,
     <xref rid="B28-vetsci-02-00456" ref-type="bibr">28</xref>,
     <xref rid="B29-vetsci-02-00456" ref-type="bibr">29</xref>]
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">effective in some cats (e.g., with stomatitis, neurological disorders)</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">I</td>
   </tr>
   <tr>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Stavudine (d4T)</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">yes [
     <xref rid="B14-vetsci-02-00456" ref-type="bibr">14</xref>,
     <xref rid="B18-vetsci-02-00456" ref-type="bibr">18</xref>,
     <xref rid="B20-vetsci-02-00456" ref-type="bibr">20</xref>,
     <xref rid="B21-vetsci-02-00456" ref-type="bibr">21</xref>,
     <xref rid="B22-vetsci-02-00456" ref-type="bibr">22</xref>,
     <xref rid="B23-vetsci-02-00456" ref-type="bibr">23</xref>,
     <xref rid="B26-vetsci-02-00456" ref-type="bibr">26</xref>,
     <xref rid="B76-vetsci-02-00456" ref-type="bibr">76</xref>]
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">nd</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">possibly effective, but no data in cats available</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IV</td>
   </tr>
   <tr>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Didanosine (ddI)</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">yes [
     <xref rid="B14-vetsci-02-00456" ref-type="bibr">14</xref>,
     <xref rid="B18-vetsci-02-00456" ref-type="bibr">18</xref>,
     <xref rid="B19-vetsci-02-00456" ref-type="bibr">19</xref>,
     <xref rid="B20-vetsci-02-00456" ref-type="bibr">20</xref>,
     <xref rid="B21-vetsci-02-00456" ref-type="bibr">21</xref>,
     <xref rid="B22-vetsci-02-00456" ref-type="bibr">22</xref>,
     <xref rid="B23-vetsci-02-00456" ref-type="bibr">23</xref>,
     <xref rid="B24-vetsci-02-00456" ref-type="bibr">24</xref>,
     <xref rid="B26-vetsci-02-00456" ref-type="bibr">26</xref>,
     <xref rid="B38-vetsci-02-00456" ref-type="bibr">38</xref>]
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">yes [
     <xref rid="B39-vetsci-02-00456" ref-type="bibr">39</xref>]
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">effective in one experimental study, but neurologic side effects</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">II</td>
   </tr>
   <tr>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Zalcitabine (ddC)</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">yes [
     <xref rid="B14-vetsci-02-00456" ref-type="bibr">14</xref>,
     <xref rid="B15-vetsci-02-00456" ref-type="bibr">15</xref>,
     <xref rid="B17-vetsci-02-00456" ref-type="bibr">17</xref>,
     <xref rid="B19-vetsci-02-00456" ref-type="bibr">19</xref>,
     <xref rid="B21-vetsci-02-00456" ref-type="bibr">21</xref>,
     <xref rid="B22-vetsci-02-00456" ref-type="bibr">22</xref>,
     <xref rid="B23-vetsci-02-00456" ref-type="bibr">23</xref>,
     <xref rid="B26-vetsci-02-00456" ref-type="bibr">26</xref>,
     <xref rid="B47-vetsci-02-00456" ref-type="bibr">47</xref>]
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">nd</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">possibly effective, but toxic</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IV</td>
   </tr>
   <tr>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lamivudine (3TC)</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">yes [
     <xref rid="B16-vetsci-02-00456" ref-type="bibr">16</xref>,
     <xref rid="B17-vetsci-02-00456" ref-type="bibr">17</xref>,
     <xref rid="B20-vetsci-02-00456" ref-type="bibr">20</xref>,
     <xref rid="B21-vetsci-02-00456" ref-type="bibr">21</xref>,
     <xref rid="B22-vetsci-02-00456" ref-type="bibr">22</xref>,
     <xref rid="B23-vetsci-02-00456" ref-type="bibr">23</xref>,
     <xref rid="B76-vetsci-02-00456" ref-type="bibr">76</xref>]
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">no [
     <xref rid="B41-vetsci-02-00456" ref-type="bibr">41</xref>]
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">not very effective, toxic in high dosages</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">II</td>
   </tr>
   <tr>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Emtricitabine (FTC)</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">yes [
     <xref rid="B17-vetsci-02-00456" ref-type="bibr">17</xref>,
     <xref rid="B20-vetsci-02-00456" ref-type="bibr">20</xref>,
     <xref rid="B21-vetsci-02-00456" ref-type="bibr">21</xref>,
     <xref rid="B22-vetsci-02-00456" ref-type="bibr">22</xref>]
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">nd</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">possibly effective, but no data in cats available</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IV</td>
   </tr>
   <tr>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Abacavir (ABC)</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">yes [
     <xref rid="B20-vetsci-02-00456" ref-type="bibr">20</xref>]
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">nd</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">possibly effective but toxic</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IV</td>
   </tr>
   <tr>
    <td colspan="5" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1">
     <bold>
      <italic>Nucleotide Analogue Reverse—Transcriptase Inhibitors</italic>
     </bold>
    </td>
   </tr>
   <tr>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Adefovir (PMEA)</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">yes [
     <xref rid="B28-vetsci-02-00456" ref-type="bibr">28</xref>]
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">no [
     <xref rid="B47-vetsci-02-00456" ref-type="bibr">47</xref>,
     <xref rid="B48-vetsci-02-00456" ref-type="bibr">48</xref>,
     <xref rid="B49-vetsci-02-00456" ref-type="bibr">49</xref>,
     <xref rid="B50-vetsci-02-00456" ref-type="bibr">50</xref>,
     <xref rid="B51-vetsci-02-00456" ref-type="bibr">51</xref>,
     <xref rid="B52-vetsci-02-00456" ref-type="bibr">52</xref>]
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">effective in some cats, but relatively toxic</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">I</td>
   </tr>
   <tr>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tenofovir (PMPA)</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">yes [
     <xref rid="B25-vetsci-02-00456" ref-type="bibr">25</xref>,
     <xref rid="B35-vetsci-02-00456" ref-type="bibr">35</xref>,
     <xref rid="B45-vetsci-02-00456" ref-type="bibr">45</xref>]
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">nd</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">possibly effective, but also likely relatively toxic</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IV</td>
   </tr>
   <tr>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <bold>
      <italic>Non-Nucleoside Reverse Transcriptase Inhibitor</italic>
     </bold>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"> </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"> </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"> </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"> </td>
   </tr>
   <tr>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Suramin</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">no</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">nd</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">likely too toxic</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IV</td>
   </tr>
   <tr>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <bold>
      <italic>Nucleotide Synthesis Inhibitors</italic>
     </bold>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"> </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"> </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"> </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"> </td>
   </tr>
   <tr>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Foscarnet (PFA)</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">yes [
     <xref rid="B14-vetsci-02-00456" ref-type="bibr">14</xref>]
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">nd </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">effective 
     <italic>in vitro</italic>, but too toxic
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IV</td>
   </tr>
   <tr>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ribavirin</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">yes [
     <xref rid="B23-vetsci-02-00456" ref-type="bibr">23</xref>,
     <xref rid="B76-vetsci-02-00456" ref-type="bibr">76</xref>]
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">nd </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">possibly effective, but too toxic in cats</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IV</td>
   </tr>
   <tr>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <bold>
      <italic>Receptor Homologues/Antagonists</italic>
     </bold>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"> </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"> </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"> </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"> </td>
   </tr>
   <tr>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Plerixafor</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">yes [
     <xref rid="B82-vetsci-02-00456" ref-type="bibr">82</xref>]
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">yes [
     <xref rid="B53-vetsci-02-00456" ref-type="bibr">53</xref>]
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">some effect in a study in privately-owened cats (thus, can be considered as treatment)</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">I</td>
   </tr>
   <tr>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <bold>
      <italic>Protease Inhibitors</italic>
     </bold>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"> </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"> </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"> </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"> </td>
   </tr>
   <tr>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tipranavir</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">yes [
     <xref rid="B85-vetsci-02-00456" ref-type="bibr">85</xref>]
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">nd</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">potentially effective, but no 
     <italic>in vivo</italic> data available
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IV</td>
   </tr>
   <tr>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lopinavir</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">yes [
     <xref rid="B85-vetsci-02-00456" ref-type="bibr">85</xref>]
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">nd</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">likely ineffective</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IV</td>
   </tr>
   <tr>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Atazanavir</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">yes [
     <xref rid="B85-vetsci-02-00456" ref-type="bibr">85</xref>]
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">nd</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">likely ineffective</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IV</td>
   </tr>
   <tr>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <bold>
      <italic>Integrase Inhibitors</italic>
     </bold>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"> </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"> </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"> </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"> </td>
   </tr>
   <tr>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Raltegravir</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">yes [
     <xref rid="B85-vetsci-02-00456" ref-type="bibr">85</xref>]
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">nd</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">possibly effective, but no data in FIV-infected cats available </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IV</td>
   </tr>
   <tr>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <bold>
      <italic>Interferons</italic>
     </bold>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"> </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"> </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"> </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"> </td>
   </tr>
   <tr>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Human interferon-α (IFN-α) SC high dose (10
     <sup>6</sup> U/kg q 24 h on five consecutive days)
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">yes [
     <xref rid="B105-vetsci-02-00456" ref-type="bibr">105</xref>]
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">no [
     <xref rid="B100-vetsci-02-00456" ref-type="bibr">100</xref>]
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">likely ineffective</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IV</td>
   </tr>
   <tr>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SC intermediate dose (10
     <sup>5</sup> U/kg q 24 h for 90 days)
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">yes [
     <xref rid="B105-vetsci-02-00456" ref-type="bibr">105</xref>]
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">nd</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">likely ineffective</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IV</td>
   </tr>
   <tr>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PO low dose (50 U/kg every 24 h for long-term period)</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">yes [
     <xref rid="B105-vetsci-02-00456" ref-type="bibr">105</xref>]
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">yes [
     <xref rid="B106-vetsci-02-00456" ref-type="bibr">106</xref>]
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">some efficacy (most likely through effect on secondary infection)</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">I</td>
   </tr>
   <tr>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Feline interferon-ω (IFN-ω) SC high dose 10
     <sup>6</sup> U/kg q 24 h on FIVe consecutive days
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">yes [
     <xref rid="B105-vetsci-02-00456" ref-type="bibr">105</xref>]
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">yes [
     <xref rid="B107-vetsci-02-00456" ref-type="bibr">107</xref>]
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">some improvement of clinical signs (most likely through effect on secondary infection)</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">I</td>
   </tr>
   <tr>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PO intermediate dose 10
     <sup>5</sup> U/cat q 24 h for 90 consecutive days
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">yes [
     <xref rid="B105-vetsci-02-00456" ref-type="bibr">105</xref>]
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">yes [
     <xref rid="B108-vetsci-02-00456" ref-type="bibr">108</xref>]
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">potentially some efficacy (most likely through effect on secondary infection)</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">III</td>
   </tr>
   <tr>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PO low dose 10
     <sup>5</sup> U/cat q 24 h for 90 consecutive days
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">yes [
     <xref rid="B105-vetsci-02-00456" ref-type="bibr">105</xref>]
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">nd</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">potentially effective (most likely through effect on secondary infection)</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IV</td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <fn>
   <p>
    <italic>FIV</italic>, feline immunodeficiency virus; 
    <italic>nd</italic>, not determined.
   </p>
   <p>
    <bold>EBM, evidence based medicine [
     <xref rid="B4-vetsci-02-00456" ref-type="bibr">4</xref>,
     <xref rid="B110-vetsci-02-00456" ref-type="bibr">110</xref>]:
    </bold>
   </p>
   <p>EBM grade I = This is the best evidence, comprising data obtained from properly designed, randomized controlled clinical trials in the target species (in this context cats).</p>
   <p>EBM grade II = Data obtained from properly designed, randomized controlled studies in the target species with spontaneous disease in an experimental setting.</p>
   <p>EBM grade III = Data based on non-randomized clinical trials, multiple case series, other experimental studies, and dramatic results from uncontrolled studies.</p>
   <p>EBM grade IV = Expert opinion, case reports, studies in other species, pathophysiological justification.</p>
  </fn>
 </table-wrap-foot>
</table-wrap>
